FDA Inspection 986993 — Biocodex
The FDA completed an inspection of Biocodex on Sep 16, 2016 in Beauvais. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 16, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Beauvais (France)
Additional details
Sponsor, Contract Research Organization